BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Helm JS, Rudel RA. Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Arch Toxicol 2020;94:1511-49. [PMID: 32399610 DOI: 10.1007/s00204-020-02752-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Grandt CL, Brackmann LK, Poplawski A, Schwarz H, Hummel-Bartenschlager W, Hankeln T, Kraemer C, Marini F, Zahnreich S, Schmitt I, Drees P, Mirsch J, Grabow D, Schmidberger H, Binder H, Hess M, Galetzka D, Marron M. Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study. Mol Med 2022;28:105. [PMID: 36068491 DOI: 10.1186/s10020-022-00520-6] [Reference Citation Analysis]
2 Tollefsen KE, Alonzo F, Beresford NA, Brede DA, Dufourcq-Sekatcheff E, Gilbin R, Horemans N, Hurem S, Laloi P, Maremonti E, Oughton D, Simon O, Song Y, Wood MD, Xie L, Frelon S. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network. Int J Radiat Biol 2022;:1-16. [PMID: 35976054 DOI: 10.1080/09553002.2022.2110317] [Reference Citation Analysis]
3 Kay JE, Cardona B, Rudel RA, Vandenberg LN, Soto AM, Christiansen S, Birnbaum LS, Fenton SE. Chemical Effects on Breast Development, Function, and Cancer Risk: Existing Knowledge and New Opportunities. Curr Environ Health Rep 2022. [PMID: 35984634 DOI: 10.1007/s40572-022-00376-2] [Reference Citation Analysis]
4 Chauhan V, Hamada N, Wilkins R, Garnier-Laplace J, Laurier D, Beaton D, Tollefsen KE. A high-level overview of the Organisation for Economic Co-operation and Development Adverse Outcome Pathway Programme. Int J Radiat Biol 2022;:1-17. [PMID: 35938955 DOI: 10.1080/09553002.2022.2110311] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Del'haye GG, Nulmans I, Bouteille SP, Sermon K, Wellekens B, Rombaut M, Vanhaecke T, Vander Heyden Y, De Kock J. Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease. Arch Toxicol 2022. [PMID: 35927586 DOI: 10.1007/s00204-022-03351-w] [Reference Citation Analysis]
6 Tanabe S, O'Brien J, Tollefsen KE, Kim Y, Chauhan V, Yauk C, Huliganga E, Rudel RA, Kay JE, Helm JS, Beaton D, Filipovska J, Sovadinova I, Garcia-Reyero N, Mally A, Poulsen SS, Delrue N, Fritsche E, Luettich K, La Rocca C, Yepiskoposyan H, Klose J, Danielsen PH, Esterhuizen M, Jacobsen NR, Vogel U, Gant TW, Choi I, FitzGerald R. Reactive Oxygen Species in the Adverse Outcome Pathway Framework: Toward Creation of Harmonized Consensus Key Events. Front Toxicol 2022;4:887135. [PMID: 35875696 DOI: 10.3389/ftox.2022.887135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pillo G, Mascolo MG, Zanzi C, Rotondo F, Serra S, Bortone F, Grilli S, Vaccari M, Jacobs MN, Colacci A. Mechanistic Interrogation of Cell Transformation In Vitro: The Transformics Assay as an Exemplar of Oncotransformation. Int J Mol Sci 2022;23:7603. [PMID: 35886950 DOI: 10.3390/ijms23147603] [Reference Citation Analysis]
8 Chauhan V, Hamada N, Garnier-Laplace J, Laurier D, Beaton D, Tollefsen KE, Locke PA. Establishing a Communication and Engagement Strategy to Facilitate the Adoption of the Adverse Outcome Pathways in Radiation Research and Regulation. Int J Radiat Biol 2022;:1-22. [PMID: 35666945 DOI: 10.1080/09553002.2022.2086716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wu D, Yang T, Hu S, Candy Chen H. Multiple oxidative and advanced oxidative modifications of hemoglobin in gastric cancer patients measured by nanoflow LC-MS/MS. Clinica Chimica Acta 2022;531:137-44. [DOI: 10.1016/j.cca.2022.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel) 2022;14:2569. [PMID: 35626173 DOI: 10.3390/cancers14102569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Song D, Zhang D, Chen S, Wu J, Hao Q, Zhao L, Ren H, Du N. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer. Sci Rep 2022;12:6946. [PMID: 35484177 DOI: 10.1038/s41598-022-10561-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Paini A, Campia I, Cronin MTD, Asturiol D, Ceriani L, Exner TE, Gao W, Gomes C, Kruisselbrink J, Martens M, Meek MEB, Pamies D, Pletz J, Scholz S, Schüttler A, Spînu N, Villeneuve DL, Wittwehr C, Worth A, Luijten M. Towards a qAOP framework for predictive toxicology - Linking data to decisions. Comput Toxicol 2022;21:100195. [PMID: 35211660 DOI: 10.1016/j.comtox.2021.100195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhang T, Wu DM, Luo PW, Liu T, Han R, Deng SH, He M, Zhao YY, Xu Y. CircNEIL3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating PIF1 through miR-1184 inhibition. Cell Death Dis 2022;13:167. [PMID: 35190532 DOI: 10.1038/s41419-022-04561-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Park DJ, Park S, Ma SW, Seo H, Lee SG, Lee K. Assessment of risks for breast cancer in a flight attendant exposed to night shift work and cosmic ionizing radiation: a case report. Ann Occup Environ Med 2022;34:e5. [DOI: 10.35371/aoem.2022.34.e5] [Reference Citation Analysis]
15 Chauhan V, Beaton D, Hamada N, Wilkins R, Burtt J, Leblanc J, Cool D, Garnier-Laplace J, Laurier D, Le Y, Yamada Y, Tollefsen KE. Adverse Outcome Pathway: A Path towards better Data Consolidation and Global Co-ordination of Radiation Research. Int J Radiat Biol 2021;:1-26. [PMID: 34919011 DOI: 10.1080/09553002.2021.2020363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Al-Taie Z, Hannink M, Mitchem J, Papageorgiou C, Shyu CR. Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer. Cancers (Basel) 2021;13:6278. [PMID: 34944904 DOI: 10.3390/cancers13246278] [Reference Citation Analysis]
17 Cardona B, Rudel RA. Application of an in Vitro Assay to Identify Chemicals That Increase Estradiol and Progesterone Synthesis and Are Potential Breast Cancer Risk Factors. Environ Health Perspect 2021;129:77003. [PMID: 34287026 DOI: 10.1289/EHP8608] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 El-Nekeety AA, Hassan ME, Hassan RR, Elshafey OI, Hamza ZK, Abdel-Aziem SH, Hassan NS, Abdel-Wahhab MA. Nanoencapsulation of basil essential oil alleviates the oxidative stress, genotoxicity and DNA damage in rats exposed to biosynthesized iron nanoparticles. Heliyon 2021;7:e07537. [PMID: 34345731 DOI: 10.1016/j.heliyon.2021.e07537] [Reference Citation Analysis]
19 da Motta KP, Lemos BB, Paltian JJ, Reis ASD, Blödorn GB, Alves D, Luchese C, Wilhelm EA. 7-Chloro-4-(phenylselanyl) quinoline reduces renal oxidative stress induced by oxaliplatin in mice. Can J Physiol Pharmacol 2021;:1-10. [PMID: 34015230 DOI: 10.1139/cjpp-2021-0090] [Reference Citation Analysis]
20 Lin X, Wang ZY, Xue G, Qin XJ, Wu JF, Zhang G. ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma. J Cancer 2021;12:3997-4010. [PMID: 34093805 DOI: 10.7150/jca.50743] [Reference Citation Analysis]
21 Chen HC, Liao KC, Tu CW. Quantitation of Nitration, Chlorination, and Oxidation in Hemoglobin of Breast Cancer Patients by Nanoflow Liquid Chromatography Tandem Mass Spectrometry. Chem Res Toxicol 2021;34:1664-71. [PMID: 33909420 DOI: 10.1021/acs.chemrestox.1c00075] [Reference Citation Analysis]
22 Chauhan V, Villeneuve D, Cool D. Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment. Int J Radiat Biol 2021;97:815-23. [PMID: 33253609 DOI: 10.1080/09553002.2020.1857456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Dou J, Puttabyatappa M, Padmanabhan V, Bakulski KM. Developmental programming: Adipose depot-specific transcriptional regulation by prenatal testosterone excess in a sheep model of PCOS. Mol Cell Endocrinol 2021;523:111137. [PMID: 33359827 DOI: 10.1016/j.mce.2020.111137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 El-Benhawy SA, El-Tahan RA, Nakhla SF. Exposure to Radiation During Work Shifts and Working at Night Act as Occupational Stressors Alter Redox and Inflammatory Markers. Arch Med Res 2021;52:76-83. [PMID: 33039210 DOI: 10.1016/j.arcmed.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Song Y, Xie L, Lee Y, Tollefsen KE. De Novo Development of a Quantitative Adverse Outcome Pathway (qAOP) Network for Ultraviolet B (UVB) Radiation Using Targeted Laboratory Tests and Automated Data Mining. Environ Sci Technol 2020;54:13147-56. [DOI: 10.1021/acs.est.0c03794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]